文献速递头颈外科咽喉与嗓音

喉癌临床分期与病理分期的差异及其对结局的影响

Clinical Versus Pathologic Laryngeal Cancer Staging and the Impact of Stage Change on Outcomes.
PubMed 文献 · Laryngoscope · 2020-07-21

分期改变与复发相关,降期患者复发风险更低。

要点

  • 约三分之一患者全喉切除术后临床分期发生改变。
  • 临床T分期不准确率18%,N分期不准确率24%。
  • 分期改变与复发相关,降期患者复发风险更低。

核心结论

  • 约三分之一喉癌患者全喉切除术后分期发生改变,临床T和N分期不准确率分别为18%和24%,分期改变与复发风险相关。

主要发现

  • 47例(17.7%,准确率0.969±0.010标准误)在T1-2与T3-4间发生分期改变。
  • 挽救性患者分期改变可能性更低(降期OR=0.20,95%CI 0.08-0.50,P<.001;升期OR=0.41,95%CI 0.23-0.74,P=.003),但N分期不准确更常见(39.8% vs. 11.7%,P<.001)。
  • 分期改变与复发相关(P=.047),降期患者复发风险更低(HR=0.26,95%CI 0.08-0.82,P=.021)。
  • 分期改变与PET扫描、亚区、手术时间或死亡率无关。

临床怎么用

  • 喉癌临床分期存在一定不准确性,术后病理分期应作为预后评估和辅助治疗决策的重要依据。
  • 对临床分期与病理分期不一致的患者,尤其是降期患者,需关注复发风险差异。

局限性

  • 回顾性队列研究,证据等级为3级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Evaluate the impact and accuracy of clinical laryngeal cancer staging. STUDY DESIGN: Retrospective cohort study. METHODS: Two hundred sixty-five consecutive patients with laryngeal squamous cell carcinoma who underwent total laryngectomy from 2001 to 2017 were studied. Clinical versus pathologic tumor (T) and nodal (N) categories were compared. Logistic regression and Cox proportional hazards analyzed the association of stage change with perioperative factors and outcomes. RESULTS: Forty-seven patients (17.7%, accuracy = 0.969 ± 0.010 [standard error]) changed between T1-2 and T3-4. Sixty-four patients (24.1%, accuracy = 0.866 ± 0.020) had inaccurate N category. Salvage patients were less likely to have stage change (downstage: odds ratio [OR] = 0.20, 95% confidence interval [CI]: 0.08-0.50, P < .001; upstage: OR = 0.41, 95% CI: 0.23-0.74, P = .003), but more likely to have inaccurate nodal category (39.8% vs. 11.7%, P < .001). Patients with stage change tended to have greater odds of positive/close margins (upstage: OR = 1.78, 95% CI: 0.91-3.5, P = .092) and chemotherapy (downstage: OR = 2.21, 95% CI: 0.80-6.14, P = .128; upstage: OR = 1.87, 95% CI: 0.85-4.11, P = .119). Stage change was associated with recurrence (P = .047) with downstaged patients less likely to recur (hazard ratio = 0.26, 95% CI: 0.08-0.82, P = .021). Stage change was not associated with positron emission tomography scan, subsite, time to surgery, or mortality. CONCLUSIONS: A third of laryngeal cancer patients were downstaged or upstaged after laryngectomy with 18% and 24% of clinical T and N categories inaccurate, respectively. Stage change was less common for salvage patients and associated with risk of recurrence. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:559-565, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Contrera KJ, Hair BB, Prendes B, et al. Clinical Versus Pathologic Laryngeal Cancer Staging and the Impact of Stage Change on Outcomes. Laryngoscope. 2020. PMID: 32692866. doi:10.1002/lary.28924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。